Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment	Cognition Disorders, Cognitive Dysfunction, cognitive disorder, psychiatric disorder	Recruiting	Not applicable	2025-05-04		NCT06951932

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria	24
Dr. Schär AG / SPA	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Clinical Trial Center	Alessandria	Italy	4

Clinical trials